IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,194 | -91.6% | 6,032 | -86.1% | 0.00% | – |
| Q2 2023 | $120,969 | +759.8% | 43,514 | +462.9% | 0.00% | – |
| Q1 2023 | $14,070 | -98.7% | 7,731 | -96.4% | 0.00% | -100.0% |
| Q4 2022 | $1,077,907 | -42.0% | 212,605 | -43.1% | 0.00% | 0.0% |
| Q3 2022 | $1,857,000 | +3276.4% | 373,644 | +2437.0% | 0.00% | – |
| Q2 2022 | $55,000 | -89.5% | 14,728 | -84.2% | 0.00% | – |
| Q1 2022 | $523,000 | -77.6% | 93,172 | -75.7% | 0.00% | -100.0% |
| Q4 2021 | $2,332,000 | +29.8% | 383,495 | +107.9% | 0.00% | 0.0% |
| Q3 2021 | $1,797,000 | -58.1% | 184,476 | -38.5% | 0.00% | -66.7% |
| Q2 2021 | $4,286,000 | +6.0% | 300,113 | +76.3% | 0.00% | 0.0% |
| Q1 2021 | $4,042,000 | – | 170,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |